Pseudobulbar Affect
📧 Sign up to get email alerts when something new happens for Pseudobulbar Affect.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-10-29Clinical Trial Update: Nuedexta in the Treatment of Pseudobulbar Affect in Patients With Alzheimer's Disease [Phase 4]
Phase 4 clinical trial update for Nuedexta in treating pseudobulbar affect in patients with Alzheimer's disease; study status terminated.
-
CLINICAL_TRIALS trial_result · 2017-07-03Clinical Trial Update: Effectiveness, Safety, and Health-Related Outcomes of NUEDEXTA® in Nursing Home Patients With Pseudobulbar Affect (PBA) [Phase 4]
Phase 4 trial evaluating effectiveness, safety, and health-related outcomes of NUEDEXTA in nursing home patients with pseudobulbar affect wa…
-
CLINICAL_TRIALS trial_result · 2017-03-15Clinical Trial Update: Safety, Tolerability and Effectiveness of Nuedexta in the Treatment of Pseudobulbar Affect (PBA) [Phase 4]
Phase 4 trial evaluating the safety, tolerability and effectiveness of Nuedexta in treating Pseudobulbar Affect; results from the study have…
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Safety and Efficacy of AVP-923 for Pseudobulbar Affect in Multiple Sclerosis Patients [Phase 3]
This clinical trial update covers safety and efficacy data from a Phase 3 study of AVP-923 for pseudobulbar affect in patients with multiple…
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS [Phase 3]
Phase 3 trial assessing safety and efficacy of AVP-923 for pseudobulbar affect in patients with ALS or MS; results were posted in 2013.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.